Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
2.635
+0.095 (3.74%)
Sep 11, 2024, 3:29 PM EDT - Market open
Clover Health Investments Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Hold Maintains $1 → $1.5 | Hold | Maintains | $1 → $1.5 | -43.07% | Aug 11, 2023 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +13.85% | Mar 6, 2023 |
Credit Suisse | Credit Suisse | Sell Maintains $2.5 → $1.25 | Sell | Maintains | $2.5 → $1.25 | -52.56% | Mar 6, 2023 |
Citigroup | Citigroup | Hold Maintains $3.5 → $1.8 | Hold | Maintains | $3.5 → $1.8 | -31.69% | Nov 16, 2022 |
SVB Leerink | SVB Leerink | Hold Maintains $3 → $1.5 | Hold | Maintains | $3 → $1.5 | -43.07% | Nov 8, 2022 |
Citigroup | Citigroup | Hold Maintains $3 → $3.5 | Hold | Maintains | $3 → $3.5 | +32.83% | Aug 9, 2022 |
Credit Suisse | Credit Suisse | Sell Maintains $3.5 → $3 | Sell | Maintains | $3.5 → $3 | +13.85% | Aug 9, 2022 |
SVB Leerink | SVB Leerink | Hold Maintains $2.5 → $3 | Hold | Maintains | $2.5 → $3 | +13.85% | May 10, 2022 |
SVB Leerink | SVB Leerink | Hold Maintains $3 → $2.5 | Hold | Maintains | $3 → $2.5 | -5.12% | Feb 25, 2022 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +127.70% | Feb 2, 2022 |
Cowen & Co. | Cowen & Co. | Sell → Hold Upgrades $7 → $3 | Sell → Hold | Upgrades | $7 → $3 | +13.85% | Feb 2, 2022 |
SVB Leerink | SVB Leerink | Hold Initiates $3 | Hold | Initiates | $3 | +13.85% | Jan 19, 2022 |
Credit Suisse | Credit Suisse | Hold → Sell Downgrades $9 → $3.5 | Hold → Sell | Downgrades | $9 → $3.5 | +32.83% | Jan 7, 2022 |
Credit Suisse | Credit Suisse | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Nov 15, 2021 |
Cowen & Co. | Cowen & Co. | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Sep 10, 2021 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Jul 12, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.